Julius J. Matasi

1.1k citations

38 papers · 820 indexed · h-index 16

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 10%
Physiology
Physiology top 5%

Co-authors: Huw M. L. Davies James W. Herndon Deen Tulshian Craig Thornley Nicholas Huby L. Mark Hodges Steven R. Childers Ahmad Fawzi
Topics: Cyclopropane Reaction Mechanisms (11 papers)Pharmacological Receptor Mechanisms and Effects (9 papers)Adenosine and Purinergic Signaling (6 papers)
Cited by: Organic Chemistry Physiology Cellular and Molecular Neuroscience
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Switzerland Bulgaria

In The Last Decade

Julius J. Matasi

38 papers receiving 776 citations

Peers

Countries citing papers authored by Julius J. Matasi

Since Specialization

Citations

This map shows the geographic impact of Julius J. Matasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius J. Matasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius J. Matasi more than expected).

Fields of papers citing papers by Julius J. Matasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julius J. Matasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius J. Matasi. The network helps show where Julius J. Matasi may publish in the future.

Co-authorship network of co-authors of Julius J. Matasi

This figure shows the co-authorship network connecting the top 25 collaborators of Julius J. Matasi. A scholar is included among the top collaborators of Julius J. Matasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julius J. Matasi. Julius J. Matasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4 2015 ·Bioorganic & Medicinal Chemistry Letters ·W. Michael Seganish,William T. McElroy,R. Jason Herr,(unknown),William J. Greenlee,J. P. Harding,Venukrishnan Komanduri,Julius J. Matasi,(unknown),Deen Tulshian,(unknown),Larry Yet,Kristine Devito,James Fossetta,Charles G. Garlisi,Daniel Lundell,Xiaoda Niu,(unknown)	7
2	Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,Deen Tulshian,(unknown),Zheng Tan,(unknown),(unknown),Julius J. Matasi,(unknown),William G. Earley,(unknown),R. Jason Herr,Xiaoping Zhou,(unknown),Diane Rindgen,Steve Sorota,Shu‐Wei Yang	10
3	Bioavailable pyrrolo-benzo-1,4-diazines as Nav1.7 sodium channel blockers for the treatment of pain 2014 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,Ginny D. Ho,Deen Tulshian,(unknown),Zheng Tan,(unknown),(unknown),Julius J. Matasi,Xianfeng Sun,(unknown),R. Jason Herr,Xiaoping Zhou,(unknown),Mark O. Urban,Jeffrey A. Vivian,Diane Rindgen,Steve Sorota	13
4	Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Deen Tulshian,Julius J. Matasi,Qiang Li,(unknown),Duane A. Burnett,William J. Greenlee,Chad Knutson,Wen‐Lian Wu,(unknown),Martin S. Domalski,Rosalia Bertorelli,Mariagrazia Grilli,Gianluca Lozza,Angelo Reggiani,Cheng Li	8
5	Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: Part 1 2011 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,(unknown),Deen Tulshian,(unknown),William J. Greenlee,Charles G. Garlisi,Hongchen Qiu,Kristine Devito,Shu‐Cheng Chen,(unknown),Rosalia Bertorelli,(unknown),Van‐Duc Le,Grégory Martin,(unknown),(unknown),(unknown)	9
6	Structure–activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain 2010 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,(unknown),Julius J. Matasi,Ginny D. Ho,Deen Tulshian,William J. Greenlee,R. Brusa,Massimiliano Beltramo,Kathleen Cox	10
7	The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Geoffrey B. Varty,Sherry Lu,Cynthia A. Morgan,Mary Cohen-Williams,Robert A. Hodgson,April Smith‐Torhan,Hongtao Zhang,Ahmad Fawzi,Michael P. Graziano,Ginny D. Ho,Julius J. Matasi,Deen Tulshian,Vicki L. Coffin,Galen Carey	67
8	Synthesis and structure–activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands: Part 2 2008 ·Bioorganic & Medicinal Chemistry Letters ·John P. Caldwell,Julius J. Matasi,Xiomara Fernandez,Robbie L. McLeod,Hongtao Zhang,Ahmad Fawzi,Deen Tulshian	9
9	3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A2A antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John P. Caldwell,William J. Greenlee,(unknown),Julius J. Matasi,Deen Tulshian,Leyla Arik,Carolyn Foster,Rosalia Bertorelli,Angela Monopoli,Ennio Ongini	14
10	Synthesis and structure–activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands 2007 ·Bioorganic & Medicinal Chemistry Letters ·John P. Caldwell,Julius J. Matasi,Hongtao Zhang,Ahmad Fawzi,Deen Tulshian	15
11	2‐(2‐Furanyl)‐7‐phenyl[1,2,4]triazolo[1,5‐c]pyrimidin‐5‐amine Analogues: Highly Potent, Orally Active, Adenosine A_2A Antagonists. Part 1. 2006 ·ChemInform ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	3
12	2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: The successful reduction of hERG activity. Part 2 2005 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Guy A. Higgins,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	15
13	The discovery and synthesis of novel adenosine receptor (A2A) antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,John P. Caldwell,Jinsong Hao,Bernard R. Neustadt,Leyla Arik,Carolyn Foster,Jean E. Lachowicz,Deen Tulshian	39
14	2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A2A antagonists. Part 1 2005 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	15
15	Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung 2000 ·European Journal of Pharmacology ·Michel R. Corboz,Maria A. Rivelli,Robert W. Egan,Deen Tulshian,Julius J. Matasi,Ahmad Fawzi,(unknown),April Smith‐Torhan,Hongtao Zhang,John A. Hey	47
16	Local cerebral metabolic effects of the novel cocaine analog, WF-31: Comparisons to fluoxetine 1997 ·Synapse ·Linda J. Porrino,(unknown),(unknown),Craig Thornley,Julius J. Matasi,Huw M. L. Davies	6
17	Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31 1997 ·Molecular Brain Research ·James B. Daunais,Stephanie Hart,(unknown),Julius J. Matasi,Craig Thornley,Huw M. L. Davies,Linda J. Porrino	5
18	Synthesis of 2.beta.-Acyl-3.beta.-aryl-8-azabicyclo[3.2.1]octanes and Their Binding Affinities at Dopamine and Serotonin Transport Sites in Rat Striatum and Frontal Cortex 1994 ·Journal of Medicinal Chemistry ·Huw M. L. Davies,Elie Saikali,Nicholas Huby,(unknown),Julius J. Matasi,Tom Sexton,Steven R. Childers	73
19	Flavonoids of polygonum senegalense (MEISN) part II: More surface and internal tissue flavonoid aglycones 1992 ·Bulletin of the Chemical Society of Ethiopia ·(unknown),Nicholas K. Gikonyo,(unknown),Julius J. Matasi,Peter G. Waterman	8
20	Anti-feedant effects of surface accumulated flavonoids of Polygonum Senegalense 1990 ·Bulletin of the Chemical Society of Ethiopia ·Jacob O. Midiwo,Eckhard Wollenweber,(unknown),Julius J. Matasi,(unknown),Peter G. Waterman	9

About Julius J. Matasi

Julius J. Matasi is a scholar working on Physiology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 38 papers that have together received 820 indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (11 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Adenosine and Purinergic Signaling (6 papers). The work is most often cited by research in Organic Chemistry (439 citations), Physiology (67 citations) and Cellular and Molecular Neuroscience (263 citations). Julius J. Matasi has collaborated with scholars based in United States, Switzerland and Bulgaria. Frequent co-authors include Huw M. L. Davies, James W. Herndon, Deen Tulshian, Craig Thornley, Nicholas Huby, L. Mark Hodges, Steven R. Childers, Ahmad Fawzi, Hongtao Zhang and John P. Caldwell. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact